Mark T. Hamann Ph.D.
Chief Scientific Officer,TrioBiotics Pharma AG
|Age||Total Calculated Compensation||This person is connected to 19 board members in 1 different organizations across 2 different industries.|
See Board Relationships
Dr. Mark T. Hamann, Ph.D., has been Chief Scientific Officer of Triton BioPharma AG at February 2009. Dr. Hamann is currently an Associate Professor of Pharmacognosy and an Associate Professor of Chemistry and Biochemistry at the University of Mississippi and an Adjunct Professor with the Center of Marine Biotechnology (COMB), University of Maryland Biotechnology Institute (UMBI). Dr. Hamann has done extensive research on the link between marine natural products and ...
--, -- --
Board Members Memberships*There is no Board Members Memberships data available.
The University of Hawai'i System
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|There is no Competitor Compensation data available.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.